Switch to:
More From Other Websites
INVESTOR ALERT: Investigation of Venaxis, Inc. Announced by Glancy Binkow & Goldberg LLP Jan 29 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Venaxis, Inc. -... Jan 29 2015
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Venaxis, Inc. Jan 29 2015
Venaxis' appendicitis test not found equivalent to standard care Jan 29 2015
Venaxis Receives FDA "Not Substantially Equivalent" Response on APPY1 510(k) Submission Jan 29 2015
6:19 am Venaxis announces the FDA has determined that the APPY1 Test does not meet the criteria for... Jan 29 2015
VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 29 2015
VENAXIS, INC. Files SEC form 8-K, Other Events Jan 07 2015
Venaxis, Inc. to Present at Biotech Showcase™ 2015 Jan 06 2015
VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 08 2014
Venaxis Files Response to FDA's Request for Additional Information Dec 03 2014
VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 03 2014
Venaxis, Inc. (APPY) in Focus: Stock Adds 7.6% in Session Nov 26 2014
VENAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 20 2014
VENAXIS, INC. Financials Nov 19 2014
Venaxis to Present at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum Nov 13 2014
10-Q for Venaxis, Inc. Nov 12 2014
VENAXIS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
Venaxis’ APPY1 Test Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14 Oct 27 2014
Venaxis' APPY1 Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14 Oct 27 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK